AbbVie (ABBV) Gains FDA Approval for Skyrizi in Children with Ps

AbbVie (ABBV) Gains FDA Approval for Skyrizi in Children with Ps  GuruFocus

Summary aggregated from GuruFocus's public RSS feed. The full reporting belongs to GuruFocus — please read it on their site.